Adjunctive antioxidants for schizophrenia vs placebo
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
Adjunctive antioxidants for schizophrenia showed no clear difference in leaving the study early, short term compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.73 [0.48, 1.11]16 studies · 1584 participantsModerate